|[December 30, 2013]
Arrayit Corporation Commences Business Operations from New Sunnyvale Headquarters
SUNNYVALE, Calif. --(Business Wire)--
Arrayit Corporation (OTCBB: ARYC),
a life sciences and molecular diagnostics leader, announces today that
the company has commenced business operations from its new corporate
headquarters located at 927 Thompson Place in Sunnyvale, California,
USA. The new corporate headquarters feature expansive modern offices and
meeting rooms, R&D, manufacturing, packaging and shipping facilities,
and cleanroom laboratories that are currently undergoing class 100
enhancements and certification for Clinical Laboratories Improvement
Amendments (CLIA) and International Organization for Standardization
(ISO) 9001 and 13485.
Arrayit develops, manufactures, markets, sells and supports patented and
proprietary microarray products and services for university
laboratories, government agencies, and life sciences, biotechnology,
diagnostics and pharmaceutical companies worldwide. The company ues its
life sciences tools revenue to fund pre-symptomatic diagnostic testing
for major treatable human conditions including ovarian cancer and
Parkinson's Disease. Arrayit OvaDx® for pre-symptomatic ovarian cancer
monitoring and screening, is scheduled for United States Food and Drug
Administration (FDA) 510(k) submission during the first half of 2014.
Arrayit expects to ship seven life sciences instruments and sixty
consumable products totaling $167,000 USD from its newly-opened company
headquarters in the remaining two business days of 2013. The revenue and
earnings from the $167K shipments will book in the fourth quarter of
2013. Reiterating the guidance provided during the November 15th
2013 conference call, the company expects higher net income for the
fourth quarter of 2013 compared to the third quarter, and double-digit
revenue growth for the full fiscal year 2013 compared to 2012.
About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray platform to
lead and empower the genetic, research, pharmaceutical, and diagnostic
communities through the discovery, development and manufacture of
proprietary life science technologies and consumables for disease
prevention, treatment and cure.
- Powerful Science for Life™
for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as
"expect", "believe", and "should". Although we believe our expectations
are reasonable, our operations involve a number of risks and
uncertainties that are beyond our control, and these statements may turn
out not to be true. Risk factors associated with our business, including
some of the facts set forth herein, are detailed in the Company's Form
10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for
the quarterly period ended September 30, 2013.
[ Back To Technology News's Homepage ]